Gene Family: CD molecules (CD)
Also known as :
"cluster of differentiation molecules",
"cluster of designation molecules"
CD molecules: The cluster of differentiation (cluster of designation) (often abbreviated as CD) is a protocol used for the identification and investigation of cell surface molecules providing targets for immunophenotyping of cells. In terms of physiology, CD molecules can act in numerous ways, often acting as receptors or ligands (the molecule that activates a receptor) important to the cell. A signal cascade is usually initiated, altering the behavior of the cell (see cell signaling). Some CD proteins do not play a role in cell signaling, but have other functions, such as cell adhesion. [Source: Wikipedia]
Genes contained within the family: 394
| Approved Symbol | Approved Name | Previous Symbols | Synonyms | Chromosome |
|---|---|---|---|---|
| CD1A | CD1a molecule | CD1 | 1q23.1 | |
| CD1B | CD1b molecule | CD1 | 1q23.1 | |
| CD1C | CD1c molecule | CD1 | 1q23.1 | |
| CD1D | CD1d molecule | 1q23.1 | ||
| CD1E | CD1e molecule | 1q23.1 | ||
| CD2 | CD2 molecule | SRBC | 1p13.1 | |
| CD3D | CD3d molecule | T3D | 11q23.3 | |
| CD3E | CD3e molecule | 11q23.3 | ||
| CD3G | CD3g molecule | 11q23.3 | ||
| CD4 | CD4 molecule | 12p13.31 | ||
| CD5 | CD5 molecule | LEU1 | T1 | 11q12.2 |
| CD6 | CD6 molecule | Tp120 | 11q12.2 | |
| CD7 | CD7 molecule | GP40, LEU-9, TP41, Tp40 | 17q25.3 | |
| CD8A | CD8a molecule | CD8 | 2p11.2 | |
| CD8B | CD8b molecule | CD8B1 | 2p11.2 | |
| CD9 | CD9 molecule | MIC3 | BA2, P24, TSPAN29, MRP-1 | 12p13.31 |
| MME | membrane metalloendopeptidase | NEP, CD10, CALLA | 3q25.2 | |
| ITGAL | integrin subunit alpha L | CD11A | LFA-1 | 16p11.2 |
| ITGAM | integrin subunit alpha M | CD11B, CR3A | MAC-1, CD11b | 16p11.2 |
| ITGAX | integrin subunit alpha X | CD11C | CD11c | 16p11.2 |
| ITGAD | integrin subunit alpha D | CD11d, ADB2 | 16p11.2 | |
| ANPEP | alanyl aminopeptidase, membrane | CD13, PEPN | LAP1, gp150, p150 | 15q26.1 |
| CD14 | CD14 molecule | 5q31.3 | ||
| FUT4 | fucosyltransferase 4 | ELFT, FCT3A, CD15 | FUC-TIV | 11q21 |
| FCGR3A | Fc fragment of IgG receptor IIIa | FCGR3, FCG3 | CD16a, CD16 | 1q23.3 |
| FCGR3B | Fc fragment of IgG receptor IIIb | FCGR3, FCG3 | CD16, CD16b | 1q23.3 |
| ITGB2 | integrin subunit beta 2 | MFI7, CD18 | LFA-1, MAC-1 | 21q22.3 |
| CD19 | CD19 molecule | 16p11.2 | ||
| MS4A1 | membrane spanning 4-domains A1 | CD20 | B1, Bp35, MS4A2 | 11q12.2 |
| CR2 | complement C3d receptor 2 | CD21, C3DR | 1q32.2 | |
| CD22 | CD22 molecule | SIGLEC-2, SIGLEC2 | 19q13.12 | |
| FCER2 | Fc fragment of IgE receptor II | CD23A, FCE2 | CLEC4J, CD23 | 19p13.2 |
| CD24 | CD24 molecule | CD24A | 6q21 | |
| IL2RA | interleukin 2 receptor subunit alpha | IL2R, IDDM10 | CD25 | 10p15.1 |
| DPP4 | dipeptidyl peptidase 4 | CD26, ADCP2 | DPPIV | 2q24.2 |
| CD27 | CD27 molecule | TNFRSF7 | S152, Tp55 | 12p13.31 |
| CD28 | CD28 molecule | 2q33.2 | ||
| CTLA4 | cytotoxic T-lymphocyte associated protein 4 | CELIAC3, IDDM12 | CD152, CD, GSE | 2q33.2 |
| ITGB1 | integrin subunit beta 1 | FNRB, MSK12, MDF2 | GPIIA, CD29 | 10p11.22 |
| TNFRSF8 | TNF receptor superfamily member 8 | D1S166E, CD30 | KI-1 | 1p36.22 |
| PECAM1 | platelet and endothelial cell adhesion molecule 1 | CD31 | 17q23.3 | |
| FCGR2A | Fc fragment of IgG receptor IIa | FCG2, FCGR2A1, FCGR2 | CDw32, IGFR2, CD32A, CD32 | 1q23.3 |
| FCGR2B | Fc fragment of IgG receptor IIb | FCG2, FCGR2 | CD32B, CD32 | 1q23.3 |
| FCGR2C | Fc fragment of IgG receptor IIc (gene/pseudogene) | CD32C, hFcRII-C | 1q23.3 | |
| CD33 | CD33 molecule | SIGLEC3, SIGLEC-3, p67, FLJ00391 | 19q13.41 | |
| CD34 | CD34 molecule | 1q32.2 | ||
| CR1 | complement C3b/C4b receptor 1 (Knops blood group) | CD35, KN | 1q32.2 | |
| CD36 | CD36 molecule | SCARB3, GPIV, FAT, GP4, GP3B | 7q21.11 | |
| CD37 | CD37 molecule | TSPAN26 | 19q13.33 | |
| CD38 | CD38 molecule | 4p15.32 | ||
| ENTPD1 | ectonucleoside triphosphate diphosphohydrolase 1 | CD39 | NTPDase-1, ATPDase, SPG64 | 10q24.1 |
| CD40 | CD40 molecule | TNFRSF5 | p50, Bp50 | 20q13.12 |
| ITGA2B | integrin subunit alpha 2b | GP2B | CD41B, PPP1R93, CD41 | 17q21.31 |
| GP9 | glycoprotein IX platelet | CD42a, GPIX | 3q21.3 | |
| GP1BA | glycoprotein Ib platelet alpha subunit | GP1B | GPIbalpha, CD42b | 17p13.2 |
| GP1BB | glycoprotein Ib platelet beta subunit | CD42c, GPIbbeta | 22q11.21 | |
| GP5 | glycoprotein V platelet | CD42d | 3q29 | |
| SPN | sialophorin | GPL115, CD43, LSN | 16p11.2 | |
| CD44 | CD44 molecule (Indian blood group) | MIC4, MDU2, MDU3 | IN, MC56, Pgp1, CD44R, HCELL, CSPG8 | 11p13 |
| PTPRC | protein tyrosine phosphatase, receptor type C | CD45 | LCA, T200, GP180 | 1q31.3-q32.1 |
| CD46 | CD46 molecule | MIC10, MCP | TRA2.10, MGC26544, TLX | 1q32.2 |
| CD47 | CD47 molecule | MER6 | IAP, OA3 | 3q13.12 |
| CD48 | CD48 molecule | BCM1 | BLAST, mCD48, hCD48, SLAMF2 | 1q23.3 |
| ITGA1 | integrin subunit alpha 1 | CD49a, VLA1 | 5q11.2 | |
| ITGA2 | integrin subunit alpha 2 | CD49B | CD49b | 5q11.2 |
| ITGA3 | integrin subunit alpha 3 | MSK18 | GAP-B3, CD49c, VLA3a, VCA-2 | 17q21.33 |
| ITGA4 | integrin subunit alpha 4 | CD49D | CD49d | 2q31.3 |
| ITGA5 | integrin subunit alpha 5 | FNRA | CD49e | 12q13.13 |
| ITGA6 | integrin subunit alpha 6 | CD49f | 2q31.1 | |
| ICAM3 | intercellular adhesion molecule 3 | ICAM-R, CD50, CDW50 | 19p13.2 | |
| ITGAV | integrin subunit alpha V | VNRA, MSK8, VTNR | CD51 | 2q32.1 |
| CD52 | CD52 molecule | CDW52 | HE5, EDDM5 | 1p36.11 |
| CD53 | CD53 molecule | MOX44 | TSPAN25 | 1p13.3 |
| ICAM1 | intercellular adhesion molecule 1 | BB2, CD54 | 19p13.2 | |
| CD55 | CD55 molecule (Cromer blood group) | DAF | CR, TC, CROM | 1q32.2 |
| NCAM1 | neural cell adhesion molecule 1 | CD56, NCAM | 11q23.2 | |
| B3GAT1 | beta-1,3-glucuronyltransferase 1 | CD57, LEU7 | GlcAT-P, HNK-1, NK-1 | 11q25 |
| CD58 | CD58 molecule | LFA3 | 1p13.1 | |
| CD59 | CD59 molecule (CD59 blood group) | MIC11, MIN1, MSK21, MIN2, MIN3 | 16.3A5, EJ16, EJ30, EL32, G344, p18-20 | 11p13 |
| ITGB3 | integrin subunit beta 3 | GP3A | CD61, GPIIIa | 17q21.32 |
| SELE | selectin E | ELAM1, ELAM | ESEL, CD62E | 1q24.2 |
| SELL | selectin L | LYAM1, LNHR | Leu-8, LSEL, LAM1, hLHRc, LAM-1, PLNHR, CD62L, Lyam-1 | 1q24.2 |
| SELP | selectin P | GRMP | CD62P, PSEL, CD62, GMP140, PADGEM | 1q24.2 |
| CD63 | CD63 molecule | MLA1 | ME491, TSPAN30 | 12q13.2 |
| FCGR1A | Fc fragment of IgG receptor Ia | CD64A, CD64 | 1q21.2 | |
| CEACAM1 | carcinoembryonic antigen related cell adhesion molecule 1 | BGP | CD66a, BGP1 | 19q13.2 |
| CEACAM8 | carcinoembryonic antigen related cell adhesion molecule 8 | CGM6 | CD66b | 19q13.2 |
| CEACAM6 | carcinoembryonic antigen related cell adhesion molecule 6 | NCA | CD66c | 19q13.2 |
| CEACAM3 | carcinoembryonic antigen related cell adhesion molecule 3 | CGM1 | CD66d | 19q13.2 |
| CEACAM5 | carcinoembryonic antigen related cell adhesion molecule 5 | CEA | CD66e | 19q13.2 |
| PSG1 | pregnancy specific beta-1-glycoprotein 1 | PSBG1 | PBG1, PSGGA, CD66f | 19q13.2 |
| CD68 | CD68 molecule | SCARD1, macrosialin, GP110, DKFZp686M18236, LAMP4 | 17p13.1 | |
| CD69 | CD69 molecule | CLEC2C | 12p13.31 | |
| CD70 | CD70 molecule | CD27LG, TNFSF7 | CD27L | 19p13.3 |
| TFRC | transferrin receptor | p90, TFR1, CD71 | 3q29 | |
| CD72 | CD72 molecule | LYB2, CD72b | 9p13.3 | |
| NT5E | 5'-nucleotidase ecto | NT5 | CALJA, eN, eNT, CD73 | 6q14.3 |
| CD74 | CD74 molecule | DHLAG | 5q33.1 | |
| CD79A | CD79a molecule | IGA | MB-1 | 19q13.2 |
| CD79B | CD79b molecule | IGB | B29 | 17q23.3 |
| CD80 | CD80 molecule | CD28LG, CD28LG1 | B7.1, B7-1 | 3q13.33 |
| CD81 | CD81 molecule | TAPA1 | TAPA-1, TSPAN28 | 11p15.5 |
| CD82 | CD82 molecule | ST6, KAI1 | R2, IA4, TSPAN27 | 11p11.2 |
| CD83 | CD83 molecule | HB15, BL11 | 6p23 | |
| CD84 | CD84 molecule | SLAMF5, hCD84, mCD84 | 1q23.3 | |
| LILRB3 | leukocyte immunoglobulin like receptor B3 | PIRB, CD85a, LIR3, HL9, PIR-B, LIR-3, ILT5 | 19q13.42 | |
| LILRA6 | leukocyte immunoglobulin like receptor A6 | LILRB6 | CD85b, ILT8 | 19q13.42 |
| LILRB5 | leukocyte immunoglobulin like receptor B5 | LIR8, LIR-8, CD85c | 19q13.4 | |
| LILRB2 | leukocyte immunoglobulin like receptor B2 | ILT4, CD85d, LIR2, LIR-2, MIR10, MIR-10 | 19q13.4 | |
| LILRA3 | leukocyte immunoglobulin like receptor A3 | HM31, LIR-4, ILT6, HM43, CD85e, LIR4 | 19q13.4 alternate reference locus | |
| LILRA5 | leukocyte immunoglobulin like receptor A5 | LILRB7 | CD85f, CD85, LIR9, ILT11 | 19q13.42 |
| LILRA4 | leukocyte immunoglobulin like receptor A4 | CD85g, ILT7 | 19q13.42 | |
| LILRA2 | leukocyte immunoglobulin like receptor A2 | LIR-7, LIR7, CD85h, ILT1 | 19q13.4 | |
| LILRA1 | leukocyte immunoglobulin like receptor A1 | CD85i, LIR-6, LIR6 | 19q13.42 | |
| LILRB1 | leukocyte immunoglobulin like receptor B1 | PIRB, ILT2, MIR-7, CD85, PIR-B, LIR1, CD85j, LIR-1 | 19q13.42 | |
| LILRB4 | leukocyte immunoglobulin like receptor B4 | HM18, LIR-5, ILT3, LIR5, CD85k | 19q13.42 | |
| LILRP1 | leukocyte immunoglobulin-like receptor pseudogene 1 | CD85l, LILRA6P, ILT9 | 19q13.42 | |
| LILRP2 | leukocyte immunoglobulin-like receptor pseudogene 2 | CD85m, ILT10 | 19q13.42 | |
| CD86 | CD86 molecule | CD28LG2 | B7.2, B7-2 | 3q13.33 |
| PLAUR | plasminogen activator, urokinase receptor | CD87, UPAR, URKR | 19q13 | |
| C5AR1 | complement C5a receptor 1 | C5R1 | CD88, C5AR, C5A | 19q13.32 |
| FCAR | Fc fragment of IgA receptor | CD89 | 19q13.42 | |
| THY1 | Thy-1 cell surface antigen | CD90 | 11q23.3 | |
| LRP1 | LDL receptor related protein 1 | APR, A2MR | LRP1A, LRP, APOER, CD91 | 12q13.3 |
| SLC44A1 | solute carrier family 44 member 1 | CDW92 | CDw92, CHTL1, CTL1, CD92 | 9q31.1-q31.2 |
| CD93 | CD93 molecule | MXRA4, C1QR1 | C1qRP, C1qR(P), dJ737E23.1, CDw93, ECSM3 | 20p11.21 |
| KLRD1 | killer cell lectin like receptor D1 | CD94 | 12p13 | |
| FAS | Fas cell surface death receptor | FAS1, APT1, TNFRSF6 | CD95, APO-1 | 10q23.31 |
| CD96 | CD96 molecule | TACTILE | 3q13.13-q13.2 | |
| ADGRE5 | adhesion G protein-coupled receptor E5 | CD97 | TM7LN1 | 19p13.12 |
| SLC7A5 | solute carrier family 7 member 5 | MPE16, CD98, D16S469E, LAT1, E16 | 16q24.2 | |
| CD99 | CD99 molecule (Xg blood group) | MIC2 | Xp22.32 and Yp11.3 | |
| SEMA4D | semaphorin 4D | SEMAJ, C9orf164 | FLJ39737, coll-4, CD100 | 9q22.2 |
| CD101 | CD101 molecule | IGSF2 | V7 | 1p13.1 |
| ICAM2 | intercellular adhesion molecule 2 | CD102 | 17q23.3 | |
| ITGAE | integrin subunit alpha E | CD103, HUMINAE | 17p13.2 | |
| ITGB4 | integrin subunit beta 4 | CD104 | 17q25.1 | |
| ENG | endoglin | ORW1, ORW | CD105, END, HHT1 | 9q34.11 |
| VCAM1 | vascular cell adhesion molecule 1 | CD106 | 1p21.2 | |
| LAMP1 | lysosomal associated membrane protein 1 | CD107a | 13q34 | |
| LAMP2 | lysosomal associated membrane protein 2 | CD107b | Xq24 | |
| SEMA7A | semaphorin 7A (John Milton Hagen blood group) | SEMAL | H-Sema-L, CD108 | 15q24.1 |
| CD109 | CD109 molecule | FLJ38569, DKFZp762L1111, CPAMD7 | 6q13 | |
| MPL | MPL proto-oncogene, thrombopoietin receptor | CD110, TPOR | 1p34.2 | |
| NECTIN1 | nectin cell adhesion molecule 1 | HVEC, ED4, PVRL1 | PRR1, CLPED1, SK-12, PVRR1, HIgR, PRR, OFC7, CD111 | 11q23.3 |
| NECTIN2 | nectin cell adhesion molecule 2 | HVEB, PVRL2 | PVRR2, PRR2, CD112 | 19q13.32 |
| NECTIN3 | nectin cell adhesion molecule 3 | PVRL3 | CDw113, CD113, PVRR3, DKFZP566B0846, PPR3, nectin-3 | 3q13.13 |
| CSF3R | colony stimulating factor 3 receptor | CD114 | GCSFR | 1p34.3 |
| CSF1R | colony stimulating factor 1 receptor | FMS | CSFR, C-FMS, CD115 | 5q32 |
| CSF2RA | colony stimulating factor 2 receptor alpha subunit | CSF2R | CD116, alphaGMR | Xp22.32 and Yp11.3 |
| KIT | KIT proto-oncogene receptor tyrosine kinase | PBT | SCFR, C-Kit, CD117 | 4q12 |
| LIFR | LIF receptor alpha | CD118 | 5p13.1 | |
| IFNGR1 | interferon gamma receptor 1 | IFNGR | CD119 | 6q23.3 |
| TNFRSF1A | TNF receptor superfamily member 1A | TNFR1 | TNFR60, TNF-R55, TNFAR, CD120a, TNF-R, TNF-R-I | 12p13.31 |
| TNFRSF1B | TNF receptor superfamily member 1B | TNFR2 | TNFBR, TNF-R-II, TNF-R75, TNFR80, p75, CD120b | 1p36.22 |
| IL1R1 | interleukin 1 receptor type 1 | IL1R, IL1RA | CD121A, D2S1473 | 2q11.2-q12.1 |
| IL1R2 | interleukin 1 receptor type 2 | IL1RB | CD121b | 2q11.2 |
| IL2RB | interleukin 2 receptor subunit beta | IL15RB | CD122 | 22q12.3 |
| IL3RA | interleukin 3 receptor subunit alpha | CD123 | Xp22.3 and Yp13.3 | |
| IL4R | interleukin 4 receptor | CD124 | 16p12.1 | |
| IL5RA | interleukin 5 receptor subunit alpha | IL5R | CD125, CDw125 | 3p26.2 |
| IL6R | interleukin 6 receptor | CD126 | 1q21.3 | |
| IL7R | interleukin 7 receptor | CD127 | 5p13.2 | |
| IL9R | interleukin 9 receptor | CD129 | Xq28 and Yq12 | |
| IL6ST | interleukin 6 signal transducer | CD130, GP130 | 5q11.2 | |
| CSF2RB | colony stimulating factor 2 receptor beta common subunit | IL3RB | IL5RB, betaGMR, CD131 | 22q12.3 |
| IL2RG | interleukin 2 receptor subunit gamma | SCIDX1, IMD4, CIDX | CD132 | Xq13.1 |
| PROM1 | prominin 1 | PROML1, MCDR2, STGD4 | CD133, AC133, CORD12, RP41 | 4p15.32 |
| TNFRSF4 | TNF receptor superfamily member 4 | TXGP1L | OX40, CD134, ACT35 | 1p36.33 |
| FLT3 | fms related tyrosine kinase 3 | CD135, FLK2, STK1 | 13q12.2 | |
| MST1R | macrophage stimulating 1 receptor | RON, PTK8 | CD136, CDw136 | 3p21.31 |
| TNFRSF9 | TNF receptor superfamily member 9 | ILA | 4-1BB, CD137 | 1p36.23 |
| SDC1 | syndecan 1 | SDC | SYND1, syndecan, CD138 | 2p24.1 |
| PDGFRA | platelet derived growth factor receptor alpha | PDGFR2, GAS9, CD140a | 4q12 | |
| PDGFRB | platelet derived growth factor receptor beta | PDGFR | PDGFR1, CD140b, JTK12 | 5q32 |
| THBD | thrombomodulin | CD141 | 20p11.21 | |
| F3 | coagulation factor III, tissue factor | TF, CD142 | 1p21.3 | |
| ACE | angiotensin I converting enzyme | DCP1 | ACE1, CD143 | 17q23.3 |
| CDH5 | cadherin 5 | CD144, 7B4 | 16q21 | |
| MCAM | melanoma cell adhesion molecule | MUC18, CD146 | 11q23.3 | |
| BSG | basigin (Ok blood group) | OK | CD147, EMMPRIN | 19p13.3 |
| PTPRJ | protein tyrosine phosphatase, receptor type J | DEP1, CD148, HPTPeta | 11p11.2 | |
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | SLAM | CD150 | 1q23.3 |
| CD151 | CD151 molecule (Raph blood group) | SFA-1, PETA-3, TSPAN24, RAPH | 11p15.5 | |
| TNFSF8 | TNF superfamily member 8 | CD30LG | CD153 | 9q32-q33.1 |
| CD40LG | CD40 ligand | HIGM1, IMD3, TNFSF5 | CD154, gp39, TRAP, CD40L, hCD40L | Xq26.3 |
| PVR | poliovirus receptor | PVS | Tage4, CD155, Necl-5, HVED, NECL5 | 19q13.31 |
| ADAM10 | ADAM metallopeptidase domain 10 | kuz, MADM, HsT18717, CD156c | 15q21.3 | |
| ADAM8 | ADAM metallopeptidase domain 8 | MS2, CD156, CD156a | 10q26.3 | |
| ADAM17 | ADAM metallopeptidase domain 17 | TACE | cSVP, CD156B | 2p25.1 |
| BST1 | bone marrow stromal cell antigen 1 | CD157 | 4p15.32 | |
| KIR2DL1 | killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1 | cl-42, nkat1, CD158A, 47.11, p58.1 | 19q13.42 | |
| KIR2DL2 | killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 2 | CD158k, CD158B1, cl-43, nkat6 | 19q13.4 alternate reference locus | |
| KIR2DL3 | killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3 | nkat2a, nkat2, cl-6, CD158B2, p58, nkat2b | 19q13.42 | |
| KIR3DP1 | killer cell immunoglobulin like receptor, three Ig domains pseudogene 1 | CD158C, KIR3DS2P, KIRX, KIR48, KIR2DS6 | 19q13.42 | |
| KIR2DL4 | killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4 | CD158D, 15.212, 103AS | 19q13.42 | |
| KIR3DL1 | killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1 | KIR | NKB1, cl-11, CD158e2, cl-2, AMB11, NKB1B, CD158e1/2, CD158E1, nkat3 | 19q13.42 |
| KIR2DL5A | killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 5A | KIR2DL5, CD158F, KIR2DL5.1 | 19q13.4 alternate reference locus | |
| KIR2DS5 | killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 5 | nkat9, CD158G | 19q13.4 alternate reference locus | |
| KIR2DS1 | killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1 | EB6ActII, EB6ActI, CD158H | 19q13.4 alternate reference locus | |
| KIR2DS4 | killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4 | cl-39, KKA3, nkat8, CD158i | 19q13.42 | |
| KIR2DS2 | killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 2 | cl-49, nkat5, CD158J, 183ActI | 19q13.4 alternate reference locus | |
| KIR3DL2 | killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2 | nkat4a, cl-5, CD158K, nkat4, nkat4b | 19q13.42 | |
| KIR3DL3 | killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 3 | KIRC1, KIR3DL7, KIR44, CD158z | 19q13.42 | |
| KLRC1 | killer cell lectin like receptor C1 | NKG2 | NKG2-A, NKG2-B, CD159a | 12p13 |
| KLRC2 | killer cell lectin like receptor C2 | NKG2-C, CD159c | 12p13 | |
| CD160 | CD160 molecule | BY55, NK1, NK28 | 1q21.1 | |
| KLRB1 | killer cell lectin like receptor B1 | NKR | hNKR-P1A, NKR-P1, NKR-P1A, CLEC5B, CD161 | 12p13.31 |
| SELPLG | selectin P ligand | PSGL-1, CD162 | 12q24.11 | |
| CD163 | CD163 molecule | M130, MM130, SCARI1 | 12p13.31 | |
| CD164 | CD164 molecule | MUC-24, MGC-24, DFNA66 | 6q21 | |
| ALCAM | activated leukocyte cell adhesion molecule | MEMD, CD166 | 3q13.11 | |
| DDR1 | discoidin domain receptor tyrosine kinase 1 | NTRK4, PTK3A, NEP, CAK, EDDR1 | CD167, RTK6 | 6p21.33 |
| HMMR | hyaluronan mediated motility receptor | RHAMM, CD168 | 5q34 | |
| SIGLEC1 | sialic acid binding Ig like lectin 1 | SN | sialoadhesin, CD169, SIGLEC-1, FLJ00051, FLJ32150, dJ1009E24.1, FLJ00073, FLJ00055 | 20p13 |
| SIGLEC5 | sialic acid binding Ig like lectin 5 | CD33L2 | SIGLEC-5, CD170, OB-BP2 | 19q13.41 |
| L1CAM | L1 cell adhesion molecule | HSAS1, SPG1, HSAS, MASA, MIC5, S10 | CD171 | Xq28 |
| SIRPA | signal regulatory protein alpha | PTPNS1 | SIRPalpha2, SIRP, SHPS-1, SIRP-ALPHA-1, SIRPalpha, P84, CD172a, BIT, SHPS1, MFR, MYD-1 | 20p13 |
| SIRPB1 | signal regulatory protein beta 1 | CD172b, SIRP-BETA-1 | 20p13 | |
| SIRPG | signal regulatory protein gamma | SIRPB2 | SIRPgamma, CD172g, SIRP-B2, bA77C3.1 | 20p13 |
| FUT3 | fucosyltransferase 3 (Lewis blood group) | LE | CD174 | 19p13.3 |
| CD177 | CD177 molecule | PRV1, HNA2A, NB1 | 19q13.31 | |
| FASLG | Fas ligand | APT1LG1, TNFSF6 | CD178, FasL | 1q24.3 |
| VPREB1 | V-set pre-B cell surrogate light chain 1 | VpreB, CD179A | 22q11.22 | |
| IGLL1 | immunoglobulin lambda like polypeptide 1 | IGLL | IGL5, IGVPB, 14.1, CD179B | 22q11.23 |
| CD180 | CD180 molecule | LY64 | RP105, Ly78 | 5q12.3 |
| CXCR1 | C-X-C motif chemokine receptor 1 | CMKAR1, IL8RA | CDw128a, CKR-1, CD181 | 2q35 |
| CXCR2 | C-X-C motif chemokine receptor 2 | IL8RB | CD182, CMKAR2 | 2q35 |
| CXCR3 | C-X-C motif chemokine receptor 3 | GPR9 | IP10-R, CD183, CKR-L2, CMKAR3, MigR | Xq13.1 |
| CXCR4 | C-X-C motif chemokine receptor 4 | NPYR, NPY3R, NPYY3R, HM89, fusin, HSY3RR, CD184, D2S201E, LESTR | 2q22.1 | |
| CXCR5 | C-X-C motif chemokine receptor 5 | BLR1 | MDR15, CD185 | 11q23.3 |
| CXCR6 | C-X-C motif chemokine receptor 6 | BONZO, CD186, TYMSTR, STRL33 | 3p21.31 | |
| CCR1 | C-C motif chemokine receptor 1 | SCYAR1, CMKBR1 | MIP1aR, CKR-1, CD191 | 3p21.31 |
| CCR2 | C-C motif chemokine receptor 2 | CMKBR2 | FLJ78302, MCP-1-R, CC-CKR-2, CD192, CKR2 | 3p21.31 |
| CCR3 | C-C motif chemokine receptor 3 | CMKBR3 | CC-CKR-3, CKR3, CD193 | 3p21.31 |
| CCR4 | C-C motif chemokine receptor 4 | CMKBR4, CD194, ChemR13, k5-5, CKR4, CC-CKR-4 | 3p22.3 | |
| CCR5 | C-C motif chemokine receptor 5 (gene/pseudogene) | CMKBR5 | CD195, CKR5, CC-CKR-5, IDDM22, CKR-5 | 3p21.31 |
| CCR6 | C-C motif chemokine receptor 6 | STRL22 | CD196, CKR-L3, DRY-6, BN-1, GPR29, DCR2, GPR-CY4, CMKBR6 | 6q27 |
| CCR7 | C-C motif chemokine receptor 7 | CMKBR7, EBI1 | CDw197, BLR2, CD197 | 17q21.2 |
| CCR8 | C-C motif chemokine receptor 8 | CMKBRL2, CMKBR8 | CY6, TER1, CKR-L1, GPR-CY6, CDw198 | 3p22.1 |
| CCR9 | C-C motif chemokine receptor 9 | GPR28 | GPR-9-6, CDw199 | 3p21.31 |
| CD200 | CD200 molecule | MOX1, MOX2 | MRC, OX-2 | 3q13.2 |
| PROCR | protein C receptor | EPCR, CCD41, CD201 | 20q11.22 | |
| TEK | TEK receptor tyrosine kinase | VMCM | TIE2, VMCM1, CD202b, TIE-2 | 9p21.2 |
| ENPP3 | ectonucleotide pyrophosphatase/phosphodiesterase 3 | PDNP3 | B10, gp130RB13-6, PD-IBETA, CD203c | 6q23.2 |
| MSR1 | macrophage scavenger receptor 1 | SR-A, SR-AIII, SR-AII, SCARA1, SR-AI, CD204 | 8p22 | |
| LY75 | lymphocyte antigen 75 | CLEC13B, CD205, DEC-205 | 2q24.2 | |
| MRC1 | mannose receptor C-type 1 | MRC1L1 | CD206, bA541I19.1, CLEC13D, CLEC13DL | 10p12.33 |
| CD207 | CD207 molecule | Langerin, CLEC4K | 2p13.3 | |
| LAMP3 | lysosomal associated membrane protein 3 | TSC403, LAMP, DC-LAMP, CD208, DCLAMP | 3q27.1 | |
| CD209 | CD209 molecule | DC-SIGN, CDSIGN, DC-SIGN1, CLEC4L | 19p13.2 | |
| IL10RA | interleukin 10 receptor subunit alpha | IL10R | CD210a, CD210, HIL-10R, CDW210A | 11q23.3 |
| IL10RB | interleukin 10 receptor subunit beta | CRFB4, D21S58, D21S66 | CRF2-4, CDW210B, IL-10R2 | 21q22.11 |
| IL12RB1 | interleukin 12 receptor subunit beta 1 | IL12RB | CD212 | 19p13.11 |
| IL13RA1 | interleukin 13 receptor subunit alpha 1 | CD213a1, IL-13Ra, NR4 | Xq24 | |
| IL13RA2 | interleukin 13 receptor subunit alpha 2 | IL-13R, CD213a2, CT19, IL13BP | Xq23 | |
| IL15RA | interleukin 15 receptor subunit alpha | IL-15RA, CD215 | 10p15.1 | |
| IL17RA | interleukin 17 receptor A | IL17R | CD217, CDw217, IL-17RA, hIL-17R | 22q11.1 |
| IL18R1 | interleukin 18 receptor 1 | CD218a, IL-1Rrp, IL1RRP | 2q12.1 | |
| IL18RAP | interleukin 18 receptor accessory protein | AcPL, CD218b | 2q12.1 | |
| INSR | insulin receptor | CD220 | 19p13.2 | |
| IGF1R | insulin like growth factor 1 receptor | IGFR, MGC18216, IGFIR, JTK13, CD221 | 15q26.3 | |
| IGF2R | insulin like growth factor 2 receptor | CD222, MPR300, CI-MPR, MPRI, MPR1, CI-M6PR, M6P-R, CIMPR | 6q25.3 | |
| LAG3 | lymphocyte activating 3 | CD223 | 12p13.31 | |
| GGT1 | gamma-glutamyltransferase 1 | GGT | D22S732, D22S672, CD224 | 22q11.23 |
| IFITM1 | interferon induced transmembrane protein 1 | IFI17 | 9-27, CD225 | 11p15.5 |
| CD226 | CD226 molecule | DNAM-1, DNAM1, PTA1, TLiSA1 | 18q22.2 | |
| MUC1 | mucin 1, cell surface associated | PUM, MCKD1 | ADMCKD1, MCD, MCKD, ADMCKD, PEM, CD227 | 1q22 |
| MELTF | melanotransferrin | MFI2 | CD228, MTF1, FLJ38863, MTf, MGC4856, MAP97 | 3q29 |
| LY9 | lymphocyte antigen 9 | mLY9, CD229, SLAMF3, hly9 | 1q23.3 | |
| PRNP | prion protein | PRIP, GSS, CJD | CD230, AltPrP, PRP | 20p13 |
| TSPAN7 | tetraspanin 7 | MXS1, TM4SF2, MRX58 | CD231, DXS1692E, A15, TALLA-1 | Xp11.4 |
| PLXNC1 | plexin C1 | CD232, VESPR | 12q22 | |
| SLC4A1 | solute carrier family 4 member 1 (Diego blood group) | EPB3, AE1, DI, WD | CD233, SW, RTA1A, FR, WR | 17q21.31 |
| ACKR1 | atypical chemokine receptor 1 (Duffy blood group) | FY, DARC | GPD, CD234, Dfy, CCBP1 | 1q23.2 |
| GYPA | glycophorin A (MNS blood group) | MNS | GPA, CD235a, MN | 4q31.21 |
| GYPB | glycophorin B (MNS blood group) | MNS | CD235b, GPB, SS | 4q31.21 |
| GYPC | glycophorin C (Gerbich blood group) | GYPD, CD236, GPC, Ge, CD236R | 2q14.3 | |
| KEL | Kell blood group, metallo-endopeptidase | CD238, ECE3 | 7q34 | |
| BCAM | basal cell adhesion molecule (Lutheran blood group) | LU | CD239 | 19q13.32 |
| RHCE | Rh blood group CcEe antigens | RH | CD240CE | 1p36.11 |
| RHD | Rh blood group D antigen | RH | RhII, Rh4, DIIIc, Rh30a, CD240D, RhPI | 1p36.11 |
| RHAG | Rh-associated glycoprotein | RH50A, CD241, SLC42A1 | 6p12.3 | |
| ICAM4 | intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) | LW | CD242 | 19p13.2 |
| ABCB1 | ATP binding cassette subfamily B member 1 | PGY1, MDR1, CLCS | CD243, GP170, P-gp, ABC20 | 7q21.12 |
| CD244 | CD244 molecule | 2B4, NAIL, NKR2B4, Nmrk, SLAMF4 | 1q23.3 | |
| ALK | ALK receptor tyrosine kinase | CD246 | 2p23.2-p23.1 | |
| CD247 | CD247 molecule | CD3Z | CD3H, CD3Q | 1q24.2 |
| CD248 | CD248 molecule | CD164L1 | TEM1 | 11q13.2 |
| ENPEP | glutamyl aminopeptidase | gp160, CD249 | 4q25 | |
| TNFSF4 | TNF superfamily member 4 | TXGP1 | CD252, gp34, OX-40L | 1q25.1 |
| TNFSF10 | TNF superfamily member 10 | TL2, Apo-2L, CD253, TRAIL | 3q26 | |
| TNFSF11 | TNF superfamily member 11 | RANKL, ODF, CD254, OPGL, TRANCE | 13q14 | |
| TNFSF13 | TNF superfamily member 13 | APRIL, CD256 | 17p13.1 | |
| TNFSF13B | TNF superfamily member 13b | TNFSF20 | TALL-1, THANK, CD257, TALL1, BLYS, BAFF | 13q33.3 |
| TNFSF14 | TNF superfamily member 14 | LTg, CD258, HVEM-L, LIGHT | 19p13.3 | |
| TNFRSF10A | TNF receptor superfamily member 10a | DR4, CD261, Apo2, TRAILR-1 | 8p21.3 | |
| TNFRSF10B | TNF receptor superfamily member 10b | TRICKB, TRAIL-R2, DR5, CD262, TRICK2A, KILLER | 8p21.3 | |
| TNFRSF10C | TNF receptor superfamily member 10c | CD263, DcR1, LIT, TRAILR3, TRID | 8p21.3 | |
| TNFRSF10D | TNF receptor superfamily member 10d | CD264, TRUNDD, DcR2, TRAILR4 | 8p21.3 | |
| TNFRSF11A | TNF receptor superfamily member 11a | PDB2, LOH18CR1 | FEO, CD265, RANK | 18q21.33 |
| TNFRSF12A | TNF receptor superfamily member 12A | CD266, FN14, TweakR | 16p13.3 | |
| TNFRSF13B | TNF receptor superfamily member 13B | CD267, TACI, IGAD2 | 17p11.2 | |
| TNFRSF13C | TNF receptor superfamily member 13C | BAFFR, CD268 | 22q13.2 | |
| TNFRSF17 | TNF receptor superfamily member 17 | BCMA | CD269, BCM, TNFRSF13A | 16p13.13 |
| TNFRSF14 | TNF receptor superfamily member 14 | ATAR, LIGHTR, HVEM, CD270, HVEA, TR2 | 1p36.32 | |
| NGFR | nerve growth factor receptor | TNFRSF16, p75NTR, CD271 | 17q21.33 | |
| BTLA | B and T lymphocyte associated | CD272, BTLA1 | 3q13.2 | |
| PDCD1LG2 | programmed cell death 1 ligand 2 | Btdc, PDL2, CD273, B7-DC, bA574F11.2, PD-L2 | 9p24.1 | |
| CD274 | CD274 molecule | PDCD1LG1 | B7-H, B7H1, PD-L1, PDL1, B7-H1 | 9p24.1 |
| ICOSLG | inducible T-cell costimulator ligand | ICOSL | B7RP1, B7RP-1, KIAA0653, GL50, CD275, ICOS-L, B7H2, B7-H2 | 21q22.3 |
| CD276 | CD276 molecule | B7-H3, B7H3, B7RP-2 | 15q24.1 | |
| BTN3A1 | butyrophilin subfamily 3 member A1 | BTN3.1, BT3.1, CD277, BTF5 | 6p22.2 | |
| ICOS | inducible T-cell costimulator | CD278, AILIM | 2q33.2 | |
| PDCD1 | programmed cell death 1 | SLEB2 | CD279, PD1, PD-1, hSLE1 | 2q37.3 |
| MRC2 | mannose receptor C type 2 | ENDO180, CD280, KIAA0709, CLEC13E | 17q23 | |
| TLR1 | toll like receptor 1 | KIAA0012, rsc786, CD281 | 4p14 | |
| TLR2 | toll like receptor 2 | CD282, TIL4 | 4q31.3 | |
| TLR3 | toll like receptor 3 | CD283 | 4q35.1 | |
| TLR4 | toll like receptor 4 | ARMD10, TLR-4, hToll, CD284 | 9q33.1 | |
| TLR6 | toll like receptor 6 | CD286 | 4p14 | |
| TLR8 | toll like receptor 8 | CD288 | Xp22.2 | |
| TLR9 | toll like receptor 9 | CD289 | 3p21.2 | |
| TLR10 | toll like receptor 10 | CD290 | 4p14 | |
| BMPR1A | bone morphogenetic protein receptor type 1A | ACVRLK3 | CD292, ALK3 | 10q23.2 |
| BMPR1B | bone morphogenetic protein receptor type 1B | ALK6, CDw293 | 4q22.3 | |
| PTGDR2 | prostaglandin D2 receptor 2 | GPR44 | CD294, DP2, CRTH2 | 11q12.2 |
| LEPR | leptin receptor | OBR, CD295 | 1p31.3 | |
| ART1 | ADP-ribosyltransferase 1 | CD296, ART2 | 11p15.4 | |
| ART4 | ADP-ribosyltransferase 4 (Dombrock blood group) | DO | DOK1, CD297 | 12p12.3 |
| ATP1B3 | ATPase Na+/K+ transporting subunit beta 3 | CD298, FLJ29027 | 3q23 | |
| CLEC4M | C-type lectin domain family 4 member M | CD299, CD209L | HP10347, DC-SIGNR, LSIGN, DCSIGNR, DC-SIGN2 | 19p13.2 |
| CD300A | CD300a molecule | Irp60, CMRF35H, CMRF-35-H9, IRC1, IRC2, IGSF12 | 17q25.1 | |
| CD300C | CD300c molecule | CMRF35, LIR, CMRF-35A, CMRF35A, IGSF16 | 17q25.1 | |
| CD300E | CD300e molecule | CD300LE | IREM2, CLM2 | 17q25.1 |
| CLEC10A | C-type lectin domain containing 10A | CLECSF13, CLECSF14 | HML, CD301, HML2 | 17p13.1 |
| CD302 | CD302 molecule | DCL-1, KIAA0022, BIMLEC, CLEC13A | 2q24.2 | |
| CLEC4C | C-type lectin domain family 4 member C | CLECSF11, CLECSF7 | HECL, BDCA2, CD303, DLEC | 12p13.31 |
| NRP1 | neuropilin 1 | VEGF165R, NRP, CD304 | 10p11.22 | |
| LAIR1 | leukocyte associated immunoglobulin like receptor 1 | CD305 | 19q13.42 | |
| LAIR2 | leukocyte associated immunoglobulin like receptor 2 | CD306 | 19q13.42 | |
| FCRL1 | Fc receptor like 1 | IFGP1, IRTA5, CD307a, FCRH1 | 1q23.1 | |
| FCRL2 | Fc receptor like 2 | SPAP1 | FCRH2, CD307b, IRTA4 | 1q23.1 |
| FCRL3 | Fc receptor like 3 | SPAP2d, IFGP3, SPAP2a, FCRH3, SPAP2, SPAP2b, IRTA3, CD307c, SPAP2e, SPAP2c | 1q23.1 | |
| FCRL4 | Fc receptor like 4 | IGFP2, FCRH4, CD307d, IRTA1 | 1q23.1 | |
| FCRL5 | Fc receptor like 5 | FCRH5, CD307e, BXMAS1, IRTA2 | 1q23.1 | |
| KDR | kinase insert domain receptor | FLK1, VEGFR2, CD309, VEGFR | 4q12 | |
| ADGRE2 | adhesion G protein-coupled receptor E2 | EMR2 | CD312 | 19p13.12 |
| KLRK1 | killer cell lectin like receptor K1 | D12S2489E | KLR, NKG2D, CD314, NKG2-D | 12p13.2 |
| PTGFRN | prostaglandin F2 receptor inhibitor | CD9P-1, FPRP, KIAA1436, FLJ11001, SMAP-6, CD315, EWI-F | 1p13.1 | |
| IGSF8 | immunoglobulin superfamily member 8 | EWI2, PGRL, CD81P3, CD316 | 1q23.2 | |
| BST2 | bone marrow stromal cell antigen 2 | CD317, tetherin | 19p13.11 | |
| CDCP1 | CUB domain containing protein 1 | SIMA135, CD318 | 3p21.31 | |
| SLAMF7 | SLAM family member 7 | 19A, CD319, CRACC, CS1 | 1q23.3 | |
| CD320 | CD320 molecule | 8D6, 8D6A | 19p13.2 | |
| F11R | F11 receptor | JAM1 | JAMA, JAM-A, JCAM, PAM-1, CD321, JAM-1 | 1q23.3 |
| JAM2 | junctional adhesion molecule 2 | C21orf43 | JAM-B, VE-JAM, CD322, JAMB | 21q21.3 |
| CDH1 | cadherin 1 | UVO | CD324, uvomorulin | 16q22.1 |
| CDH2 | cadherin 2 | NCAD | CD325, CDHN | 18q12.1 |
| EPCAM | epithelial cell adhesion molecule | M4S1, MIC18, TACSTD1 | KS1/4, TROP1, TACST-1, MK-1, ESA, 323/A3, CD326, Ep-CAM, Ly74, EGP40, KSA, 17-1A, MOC31, HEA125, CO-17A, MH99, GA733-2, EGP-2, EGP34 | 2p21 |
| SIGLEC6 | sialic acid binding Ig like lectin 6 | CD33L, CD33L1 | CD327, SIGLEC-6, OB-BP1 | 19q13.41 |
| SIGLEC7 | sialic acid binding Ig like lectin 7 | SIGLEC19P, SIGLECP2 | CD328, QA79, p75/AIRM1, SIGLEC-7 | 19q13.41 |
| SIGLEC9 | sialic acid binding Ig like lectin 9 | CD329 | 19q13.3-q13.4 | |
| FGFR1 | fibroblast growth factor receptor 1 | FLT2, KAL2 | CEK, N-SAM, H5, BFGFR, FLG, H3, H2, CD331, H4 | 8p11.23 |
| FGFR2 | fibroblast growth factor receptor 2 | KGFR, BEK, CFD1, JWS | CD332, ECT1, TK25, CEK3, TK14, K-SAM | 10q26.13 |
| FGFR3 | fibroblast growth factor receptor 3 | ACH | JTK4, CD333, CEK2 | 4p16.3 |
| FGFR4 | fibroblast growth factor receptor 4 | CD334, JTK2 | 5q35.2 | |
| NCR1 | natural cytotoxicity triggering receptor 1 | LY94 | CD335, NK-p46, NKP46 | 19q13.42 |
| NCR2 | natural cytotoxicity triggering receptor 2 | LY95 | CD336, NK-p44 | 6p21.1 |
| NCR3 | natural cytotoxicity triggering receptor 3 | LY117 | 1C7, CD337, NKp30 | 6p21.33 |
| ABCG2 | ATP binding cassette subfamily G member 2 (Junior blood group) | BCRP, CD338, MXR, ABCP, EST157481 | 4q22.1 | |
| JAG1 | jagged 1 | AGS, JAGL1 | CD339, AWS, HJ1, AHD | 20p12.2 |
| ERBB2 | erb-b2 receptor tyrosine kinase 2 | NGL | CD340, HER2, NEU, HER-2 | 17q12 |
| FZD4 | frizzled class receptor 4 | EVR1 | CD344 | 11q14.2 |
| FZD9 | frizzled class receptor 9 | FZD3, CD349 | 7q11.23 | |
| FZD10 | frizzled class receptor 10 | CD350 | 12q24.33 | |
| FCAMR | Fc fragment of IgA and IgM receptor | FCA/MR, FKSG87, CD351 | 1q32.1 | |
| SLAMF6 | SLAM family member 6 | NTB-A, CD352, SF2000, NTBA, KALIb, Ly108, KALI | 1q23.2-q23.3 | |
| SLAMF8 | SLAM family member 8 | CD353, SBBI42, BLAME | 1q23.2 | |
| TREM1 | triggering receptor expressed on myeloid cells 1 | TREM-1, CD354 | 6p21.1 | |
| CRTAM | cytotoxic and regulatory T-cell molecule | CD355 | 11q24.1 | |
| TNFRSF18 | TNF receptor superfamily member 18 | AITR, GITR, CD357 | 1p36.33 | |
| TNFRSF21 | TNF receptor superfamily member 21 | CD358, DR6 | 6p12.3 | |
| IL21R | interleukin 21 receptor | CD360 | 16p12.1 | |
| EVI2B | ecotropic viral integration site 2B | EVDB, CD361, D17S376 | 17q11.2 | |
| SDC2 | syndecan 2 | HSPG, HSPG1 | fibroglycan, SYND2, CD362 | 8q22.1 |
| S1PR1 | sphingosine-1-phosphate receptor 1 | EDG1 | CD363, D1S3362, edg-1 | 1p21.2 |
| PI16 | peptidase inhibitor 16 | MSMBBP, MGC45378, CD364, dJ90K10.5 | 6p21.2 | |
| HAVCR1 | hepatitis A virus cellular receptor 1 | CD365, TIM1, KIM1, HAVCR, TIMD1, TIM-1, HAVCR-1 | 5q33.3 | |
| CLEC4A | C-type lectin domain family 4 member A | CLECSF6 | DCIR, CD367, DDB27 | 12p13.31 |
| CLEC4D | C-type lectin domain family 4 member D | CLECSF8 | Mpcl, CD368 | 12p13.31 |
| CLEC7A | C-type lectin domain containing 7A | CLECSF12 | hDectin-1, CD369, dectin-1, SCARE2 | 12p13.2 |
| CLEC9A | C-type lectin domain containing 9A | HEEE9341, CD370, DNGR-1, UNQ9341 | 12p13.2 | |
| CLEC12A | C-type lectin domain family 12 member A | CD371, MICL, CLL-1, DCAL-2 | 12p13.31 |
